Diagnostics & Imaging
Imaging systems; in-vitro diagnostics; molecular diagnostics; point-of-care testing; pathology.
NTM Growth %
to
EV / NTM Rev (x)
to
Mkt Cap ($B)
to
Showing 11 of 11 companies
| Company | Mkt Cap ↓ | EV | EV / LTM Rev | EV / NTM Rev | EV / LTM EBITDA | EV / NTM EBITDA | NTM Growth | Gross Margin | EBITDA Margin | FCF Margin | Rule of 40 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Median | 1.9x | 2.1x | 12.0x | 9.6x | 5.6% | 45.3% | 17.3% | 10.1% | 13.1% | |||
| Mean | 2.7x | 2.6x | 11.8x | 11.5x | 12.4% | 46.6% | -5.1% | -10.3% | 0.9% | |||
| ABTAbbott Laboratories | $183.06B | $210.07B | 4.7x | 4.0x | 18.2x | 14.8x | 19.4% | 56.8% | 21.3% | 19.7% | 39.0% | |
| BDXBecton, Dickinson and Company | $61.51B | $77.98B | 3.6x | 4.0x | 15.7x | 17.2x | -10.2% | 46.5% | 21.9% | 14.4% | 4.2% | |
| TDYTeledyne Technologies Incorporated | $31.66B | $33.35B | 5.5x | 4.9x | 22.4x | 18.7x | 10.6% | 39.0% | 24.9% | 18.7% | 29.3% | |
| GEHCGE HealthCare Technologies Inc. | $31.65B | $39.64B | 1.9x | 1.8x | 10.5x | 9.6x | 8.2% | 42.9% | 16.4% | 4.3% | 12.5% | |
| FUJIYFUJIFILM Holdings Corporation | $28.54B | $888.71B | 0.2x | 0.2x | 1.6x | 1.6x | 1.1% | 40.8% | 14.7% | -3.1% | -2.0% | |
| PHGKoninklijke Philips N.V. | $25.89B | $31.56B | 1.8x | 1.7x | 12.0x | 7.8x | 2.9% | 45.9% | 17.3% | 10.7% | 13.6% | |
| SMMNYSiemens Healthineers AG | $25.12B | $37.76B | 1.7x | 1.5x | 8.7x | 7.9x | 13.4% | 39.0% | 19.5% | 10.1% | 23.4% | |
| CAJCanon Inc. | $21.97B | $92.89B | 0.0x | — | 0.2x | — | — | 45.3% | 14.4% | 1.8% | — | |
| LNTHLantheus Holdings, Inc. | $6.58B | $6.71B | 4.4x | 4.3x | 16.6x | 7.6x | 2.2% | 60.5% | 30.6% | 24.1% | 26.3% | |
| QDELQuidelOrtho Corporation | $1.18B | $3.91B | 1.4x | 1.4x | — | 18.5x | 0.7% | 45.0% | -20.7% | -2.8% | -2.1% | |
| HYPRHyperfine, Inc. | $83M | $56M | 4.1x | 2.4x | — | — | 75.5% | 51.2% | -216.2% | -211.3% | -135.9% |